市场调查报告书
商品编码
1513768
全球裸金属支架市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Bare-metal Stents Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球裸金属支架市场需求预计将从2023年的38.1亿美元达到近62.8亿美元的市场规模,2024-2032年研究期间复合年增长率为5.69%。
裸金属支架 (BMS) 是管状网状装置,用于治疗被诊断患有冠状动脉疾病的个体狭窄或阻塞的冠状动脉。这些支架由金属製成,通常是不銹钢或钴铬合金,并透过称为血管成形术的微创手术插入动脉。 BMS 提供即时的结构支持,以保持动脉畅通,从而增强流向心臟的血液。然而,与药物洗脱支架不同,BMS 不会释放药物来预防再狭窄(动脉重新变窄)。儘管如此,与药物洗脱支架相比,由于其简单性、成本效益以及降低极晚期支架血栓形成的风险,它们仍然被广泛使用。
心血管疾病(如冠状动脉疾病)发病率的增加推动了裸金属支架市场的发展,这需要使用支架进行有效治疗。支架技术和材料的进步提高了裸金属支架的安全性和有效性,大大满足了它们的需求。此外,微创外科手术数量的不断增加以及某些患者群体对裸金属支架的日益偏好也推动了市场的成长。老年人口的不断增加,更容易患心血管疾病,进一步推动了市场的成长。政府对心血管疾病管理和改善新兴经济体医疗基础设施的措施和资金为市场成长提供了有利的环境。
此外,人们对这些支架的好处及其在各种医疗保健环境中的可用性的认识不断提高,推动了它们的采用。新型裸金属支架设计的开发以及正在进行的研发活动也对市场产生了积极影响。然而,对药物洗脱支架的日益青睐和再狭窄的风险可能会挑战未来几年的市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球裸金属支架市场的各个细分市场进行了包容性评估。裸金属支架产业的成长和趋势为本研究提供了整体方法。
裸金属支架市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲裸金属支架市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。裸金属支架市场的主要参与者包括 Abbott Laboratories、Boston Scientific Corporation、Medtronic Plc、Terumo Corporation、Cook Medical、B. Braun Melsungen AG、Biotronik SE & Co. KG、Meril Life Sciences Pvt.。有限公司、Translumina GmbH、乐普医疗科技(北京)有限公司、其他。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Bare-metal Stents Market is presumed to reach the market size of nearly USD 6.28 Billion by 2032 from USD 3.81 Billion in 2023 with a CAGR of 5.69% under the study period 2024-2032.
Bare-metal stents (BMS) are tubular mesh devices used to manage narrowed or blocked coronary arteries in individuals diagnosed with coronary artery disease. These stents are made of metal, typically stainless steel or cobalt-chromium, and are inserted into the artery via a minimally invasive procedure called angioplasty. BMS provides immediate structural support to keep the artery open, enhancing blood flow to the heart. However, unlike drug-eluting stents, BMS does not release medication to prevent restenosis (re-narrowing of the artery). Despite this, they are still widely used due to their simplicity, cost-effectiveness, and reduced risk of very late stent thrombosis compared to drug-eluting stents.
The bare-metal stents market is propelled by the increasing incidence of cardiovascular diseases, like coronary artery disease, which necessitates using stents for effective treatment. Advances in stent technology and materials, enhancing the safety and efficacy of bare-metal stents, significantly contribute to their demand. Additionally, the growing number of minimally invasive surgical procedures and the increasing preference for bare-metal stents in certain patient populations propel market growth. The growing elderly population, who are more susceptible to cardiovascular conditions, further boosts the market growth. Government initiatives and funding for cardiovascular disease management and improving healthcare infrastructure in emerging economies provide a conducive environment for market growth.
Furthermore, increasing awareness about the benefits of these stents and their availability in various healthcare settings drives their adoption. The development of novel bare-metal stent designs and ongoing research and development activities also positively impact the market. However, the increasing preference for drug-eluting stents and the risk of restenosis may challenge market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Bare-metal Stents. The growth and trends of Bare-metal Stents industry provide a holistic approach to this study.
This section of the Bare-metal Stents market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Bare-metal Stents market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Bare-metal Stents market include Abbott Laboratories, Boston Scientific Corporation, Medtronic Plc, Terumo Corporation, Cook Medical, B. Braun Melsungen AG, Biotronik SE & Co. KG, Meril Life Sciences Pvt. Ltd., Translumina GmbH, Lepu Medical Technology(Beijing) Co. Ltd., Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.